Biomarkers such as cartilage oligomeric matrix protein (COMP), hyaluronic acid (HA), osteocalcin, and procollagen type I N-terminal peptide (PINP) have been identified as key indicators of musculoskeletal health and are notably affected in COVID-19 patients (Table 1). The gene discussed is COMP; the disease is COVID-19.